Page last updated: 2024-08-23

etoposide and perfosfamide

etoposide has been researched along with perfosfamide in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19907 (28.00)18.7374
1990's14 (56.00)18.2507
2000's3 (12.00)29.6817
2010's1 (4.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acaba, L; Atzpodien, J; Berman, E; Clarkson, B; Crown, J; Doherty, M; Gulati, S; Motzer, R; Reich, L; Yahalom, J1
Andoh, T; Ito, Y; Kawashima, K; Morishima, Y; Morishita, Y; Saito, H; Tanimoto, M; Towatari, M1
Bril, H; Claessen, AM; Scheper, RJ; Steerenberg, PA; Tan, BT; Valster, H1
Cheung, NK; Gulati, SC; Heller, G; Kushner, BH; O'Reilly, RJ1
Appelbaum, FR; Buckner, CD; Durnam, D; Epstein, C; Hill, R; Nemunaitis, J; Singer, JW; Storb, R; Thomas, ED1
Clarkson, BD; Fried, J; Fujita, N; Gulati, SC; Inaba, T; Murakami, S; Nakagawa, M; Shimazaki, C; Wang, CY; Wisniewolski, R1
Colvin, OM; Jones, RJ; Miller, CB; Rowley, SD; Sensenbrenner, LL; Zehnbauer, BA1
Colvin, OM; Santos, GW1
Auber, ML; Blaauw, A; Dicke, KA; Horwitz, LJ; Khorana, S; McCredie, KB; Spitzer, G; Tucker, S; Warmuth, M; Woods, T1
Atzpodien, J; Clarkson, BD; Gulati, SC; Lemoli, RM; Shimazaki, C1
Berman, E; Clarkson, B; Cunningham, I; Flomenberg, N; Gee, T; Gulati, SC; O'Reilly, RJ; Sarris, A; Shank, B1
Linch, DC; Singer, CR1
Chang, TT; Chou, TC; Clarkson, B; Colvin, M; Gulati, S1
Chang, TT; Chou, TC; Clarkson, BD; Colvin, M; Gandola, L; Gulati, SC; Ibrahim, SM; Vega, R; Yopp, J1
Castle, VP; Cooper, MJ; Dole, MG; Jasty, R; Nuñez, G; Thompson, CB1
Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S1
Aebi, S; Fink, D; Haas, M; Howell, SB; Kim, HK; Nebel, S; Norris, PS1
Adachi, K; Marunouchi, T; Saito, H; Towatari, M1
Aebi, S; Fink, D; Fink, JL; Gordon, R; Howell, SB; Kim, HK; Zheng, H1
Damon, LE; Linker, CA; Ries, CA; Rugo, HS; Wolf, JL1
Ericson, SG; Fortney, J; Gibson, LF; Landreth, KS; Lynch, JP; Magro, G1
Akutsu, M; Bai, L; Furukawa, Y; Ichikawa, A; Kano, Y; Kon, K; Suzuki, K; Tsunoda, S1
Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kobayashi, H; Mano, H; Tsunoda, S1
Clutter, SD; Fortney, JE; Gibson, LF1
Shibayama, Y; Sugawara, M; Takada, K; Takekuma, Y; Tazawa, Y; Usukubo, I1

Reviews

1 review(s) available for etoposide and perfosfamide

ArticleYear
Pharmacological purging of bone marrow with reference to autografting.
    Clinics in haematology, 1986, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic

1986

Trials

1 trial(s) available for etoposide and perfosfamide

ArticleYear
Pharmacological purging of bone marrow with reference to autografting.
    Clinics in haematology, 1986, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic

1986

Other Studies

24 other study(ies) available for etoposide and perfosfamide

ArticleYear
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow.
    Bone marrow transplantation, 1992, Volume: 10, Issue:2

    Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Survival Rate

1992
Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells.
    Cancer research, 1990, Nov-15, Volume: 50, Issue:22

    Topics: Blotting, Northern; Cyclophosphamide; Daunorubicin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Gene Expression; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured

1990
Tumor regression and induction of anti-tumor immunity by local chemotherapy of guinea-pigs bearing a line-10 hepatocarcinoma.
    International journal of cancer, 1991, Feb-20, Volume: 47, Issue:4

    Topics: Adjuvants, Immunologic; Animals; Antigens, Neoplasm; Cyclophosphamide; Etoposide; Female; Guinea Pigs; Hypersensitivity, Delayed; Immunotherapy, Adoptive; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Tumor Cells, Cultured

1991
Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro.
    Medical and pediatric oncology, 1990, Volume: 18, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Bone Marrow Transplantation; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoiesis; Humans; Infant; Melphalan; Neuroblastoma; Neutrophils; Thiotepa; Vincristine

1990
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation.
    Blood, 1990, Jul-01, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Colony-Stimulating Factors; Cyclophosphamide; Etoposide; Female; Graft Rejection; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Hematopoiesis; Humans; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Transplantation, Autologous; Transplantation, Homologous

1990
Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
    Progress in clinical and biological research, 1990, Volume: 333

    Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Magnetics; Microspheres; Multiple Myeloma; Tumor Cells, Cultured; Tumor Stem Cell Assay

1990
In vitro evaluation of combination drug purging for autologous bone marrow transplantation.
    Bone marrow transplantation, 1990, Volume: 5, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine

1990
Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia.
    Blood, 1988, Volume: 71, Issue:1

    Topics: Antineoplastic Agents; Asparaginase; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Drug Evaluation, Preclinical; Drug Interactions; Etoposide; Hydrocortisone; Leukemia, Lymphoid; Organometallic Compounds; Spiro Compounds; Tumor Cells, Cultured; Vincristine

1988
Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodies.
    European journal of haematology. Supplementum, 1989, Volume: 51

    Topics: Antibodies, Monoclonal; Cell Separation; Colony-Forming Units Assay; Cyclophosphamide; Cytotoxicity, Immunologic; Etoposide; Hematopoietic Stem Cells; Humans; Killer Cells, Natural; Magnetics; Multiple Myeloma; Tumor Cells, Cultured; Tumor Stem Cell Assay

1989
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
    Bone marrow transplantation, 1989, Volume: 4 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Etoposide; Evaluation Studies as Topic; Freezing; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Organ Preservation; Postoperative Complications; Preoperative Care; Transplantation, Autologous

1989
Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging.
    Leukemia research, 1987, Volume: 11, Issue:11

    Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Cell Survival; Clone Cells; Cyclophosphamide; Cytarabine; Etoposide; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Melphalan; Transplantation, Autologous; Tumor Cells, Cultured

1987
Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors.
    Cancer research, 1987, Jan-01, Volume: 47, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute

1987
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
    Cancer research, 1985, Volume: 45, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Computers; Cyclophosphamide; Drug Synergism; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin

1985
Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
    Cancer research, 1995, Jun-15, Volume: 55, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Cell Line; Cell Survival; Cisplatin; Cyclophosphamide; DNA Damage; DNA, Neoplasm; Etoposide; Flow Cytometry; Humans; Multigene Family; Neuroblastoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Time Factors; Transfection; Tumor Cells, Cultured

1995
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
    Blood, 1997, Apr-15, Volume: 89, Issue:8

    Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine

1997
The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.
    British journal of cancer, 1998, Volume: 77, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cell Separation; Cisplatin; Colorectal Neoplasms; Cyclophosphamide; DNA Repair; DNA, Neoplasm; Doxorubicin; Enzyme Inhibitors; Etoposide; Humans; Melphalan; Paclitaxel; Tamoxifen; Thioguanine; Tumor Cells, Cultured; Tumor Stem Cell Assay

1998
Evidence for a critical role of DNA topoisomerase IIalpha in drug sensitivity revealed by inducible antisense RNA in a human leukaemia cell line.
    British journal of haematology, 1998, Volume: 101, Issue:3

    Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Blotting, Southern; Cell Survival; Cyclophosphamide; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Gene Expression; Humans; Isoenzymes; Leukemia, Myeloid; RNA, Antisense; RNA, Messenger; Tumor Cells, Cultured

1998
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antineoplastic Agents; Carboplatin; Carrier Proteins; Cisplatin; Colorectal Neoplasms; Cyclophosphamide; DNA Adducts; DNA Damage; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methylnitronitrosoguanidine; Mutagenesis; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Thioguanine; Tumor Cells, Cultured

1997
Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
    Bone marrow transplantation, 1998, Volume: 22, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Middle Aged; Transplantation, Autologous

1998
Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
    Breast cancer research and treatment, 1999, Volume: 55, Issue:2

    Topics: Adenocarcinoma; Annexin A5; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Estrogens; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured

1999
In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
    Leukemia, 2000, Volume: 14, Issue:3

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Methotrexate; Neoplastic Stem Cells; Tumor Cells, Cultured; Vidarabine; Vidarabine Phosphate; Vincristine

2000
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
    Investigational new drugs, 2007, Volume: 25, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Cytarabine; Depsipeptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Imatinib Mesylate; Irinotecan; K562 Cells; Leukemia; Lymphoma; Mercaptopurine; Piperazines; Pyrimidines; Time Factors

2007
Chemotherapy disrupts activity of translational regulatory proteins in bone marrow stromal cells.
    Experimental hematology, 2006, Volume: 34, Issue:11

    Topics: Adaptor Proteins, Signal Transducing; Animals; Antimetabolites, Antineoplastic; Bone Marrow Cells; Cell Cycle Proteins; Cell Line; Cyclophosphamide; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Etoposide; Humans; Matrix Metalloproteinase 2; Melphalan; Mice; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Stromal Cells; Structure-Activity Relationship; TOR Serine-Threonine Kinases

2006
Schedule-dependent cytotoxicity of Etoposide and cyclophosphamide in P-glycoprotein-expressing human leukemic K-562 cells.
    Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:8

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Cycle; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Etoposide; Humans; K562 Cells; Leukemia

2014